| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Elevance Health, Inc. | EVP & Pres Carelon & CarelonRx | Common Stock | 21K | $8.71M | $414.01 | Nov 1, 2024 | Direct |
| Elevance Health, Inc. | EVP & Pres Carelon & CarelonRx | Employee Stock Option (Right to Buy) | 4.91K | Mar 4, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ELV | Elevance Health, Inc. | Nov 1, 2024 | 2 | -$683K | 4 | Nov 5, 2024 | EVP & Pres Carelon & CarelonRx |
| ELV | Elevance Health, Inc. | Mar 1, 2024 | 9 | -$10.2M | 4 | Mar 5, 2024 | EVP & Pres Carelon & CarelonRx |
| ELV | Elevance Health, Inc. | Nov 1, 2023 | 1 | -$68.8K | 4 | Nov 3, 2023 | EVP & Pres Carelon & CarelonRx |
| ELV | Elevance Health, Inc. | Mar 1, 2023 | 5 | -$2.85M | 4 | Mar 3, 2023 | EVP & Pres Carelon & CarelonRx |
| ELV | Elevance Health, Inc. | Nov 1, 2022 | 1 | -$109K | 4 | Nov 3, 2022 | EVP & Pres Carelon & IngenioRx |
| ELV | Anthem, Inc. | Mar 10, 2022 | 8 | -$7.91M | 4 | Mar 14, 2022 | EVP & Pres., DBG & IngenioRx |
| ELV | Anthem, Inc. | Mar 1, 2022 | 5 | -$2.34M | 4 | Mar 3, 2022 | EVP & Pres., DBG & IngenioRx |
| ELV | Anthem, Inc. | Nov 1, 2021 | 2 | $0 | 4 | Nov 3, 2021 | EVP & Pres., DBG & IngenioRx |
| ELV | Anthem, Inc. | Oct 31, 2018 | 1 | -$270K | 4 | May 7, 2021 | EVP & President, Commercial |